Matthew Lauber
Matthew Lauber
Matt Lauber is a Consulting Scientist at Waters. He is responsible for the development of reagent and separation technologies for the characterization of biotherapeutics.

Posts by author

When Resolving Minor Differences in Protein Therapeutics Can Have a Major Impact

By November 6, 2018

Scientists from Waters and Pfizer collaborated to take on the challenge of engineering a novel reversed-phase LC column for high-throughput separations with enhanced resolution, selectivity, and recovery of target mAbs and ADCs.

Categories: Columns, Technologies
Tags: , , ,